Prolactinoma;Adénome à prolactine

Revue du Praticien

Volumn 46, Issue 12, 1996, Pages 1486-1489

  Brue, Thierry ^a   Morange, Isabelle ^a   Jaquet, Philippe ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ARTICLE; BLOOD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPOPHYSIS TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PROLACTINOMA; SECRETION; HORMONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; SHORT SURVEY;

BROMOCRIPTINE; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY NEOPLASMS; PREGNANCY; PROLACTIN; PROLACTINOMA;

EID: 0029950606     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Thapar K, Kovac K, Laws ER, Muller PJ. Pituitary adenomas: current concept in classification histopathology and molecular biology. Endocrinologist 1993; 3: 39-57.
2. Fossati P. La prolactine. Laboratoire Behring, Laboratoire Sandoz, Rueil-Malmaison, 1991.
3. Mirakian P, Pugeat M. Hyperprolactinémie: physiopathologie-diagnostic et principes du traitement. Rev Prat (Paris) 1990; 40: 2297-300.
4. Boirie Y, Durlach V. Hyperprolactinémie (Physiopathologie, diagnostic, évolution, traitement). Impact Internat/Endocrinologie 1994; 14: 353-8.
5. Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992; 13: 220-40.
6. Molitch ME. Prolactinoma. In: Melmed S (ed). The pituitary. Blackwelle Science, 1995.